e read with interest the article by Baráth et al 1 describing the reliability of MR imaging performed 4 hours after intravenous administration of double-dose gadolinium-based contrast agent for the visualization of endolymphatic hydrops in Menière disease. Although we agree with the principal findings of the study, we would like to clarify an important technical point to further increase the practical value of the article. The authors stated that they used a 3D real inversion recovery (3D real IR) sequence using our previously reported method.
